http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
경화성 장간막염과 감별이 어려웠던 총담관암 림프절전이 1예
박호준 ( Ho Joon Park ),이반석 ( Ban Seok Lee ),서안나 ( An Na Seo ),배한익 ( Han Ik Bae ) 대한췌담도학회 2016 대한췌담도학회지 Vol.21 No.4
경화성 장간막염은 장간막에 만성 염증과 섬유화를 보이는 드문 질환으로 비교적 양호한 경과를 가지는 질환이다. 복부 컴퓨터단층촬영을 포함한 특징적 영상소견이 진단에 도움이 된다. 그러나 경화성 장간막염은 몇몇 악성 질환들과 유사한 형태를 보일 수 있으며, 이들은 치료방법 및 경과 자체가 완전히 다르기 때문에 악성 질환에 대한 적극적 배제가 중요하다. 저자들은 체중 감소 및 지속되는 설사 증상으로 내원한 75세 남성 환자가 복부 컴퓨터단층촬영상 장간막 혈관 주변 연무양 감쇄의 특징적 소견을 보여 경화성 장간막염으로 오인하였으나, 추적관찰 및 추가적으로 시행한 조직검사와 양성자방출 컴퓨터단층촬영술을 통하여 최종적으로 총담관암과 그에 동반된 림프절전이로 진단하였던 드문 증례를 경험하여 이를 보고하고자 한다. Sclerosing mesenteritis is a rare disease presenting as chronic inflammation and fibrosis of mesentery around the small and large intestine. And in most cases, it shows indolent and benign clinical course resulting in favorable prognosis. It is often diagnosed through characterized radiologic finding in abdominal examinations including computed tomography scan. However, it is important to rule out other conditions involving mesentery when diagnosing sclerosing mesenteritis. In the case of malignancy, the method of treatment and prognosis can be completely different therefore thorough examinations are essential. We herein report a 75-year-old male who suffered from frequent diarrhea and weight loss. Initially, he was diagnosed with sclerosing mesenteritis through abdominal computed tomography scan showing "misty" soft-tissue attenuation around the mesenteric vessel. However, follow up positron emission tomography scan and biopsy finding confirmed the common bile duct cancer with lymph node metastasis.
스테로이드 치료 후 광범위 절제술을 피할 수 있었던 황색 육아종성 담낭염
강진우 ( Jinwoo Kang ),이상협 ( Sang Hyub Lee ),이재우 ( Jae Woo Lee ),이주영 ( Jooyoung Lee ),박재용 ( Jae Yong Park ),이반석 ( Ban Seok Lee ),류지곤 ( Ji Kon Ryu ),김용태 ( Yong Tae Kim ) 대한췌장담도학회 2015 대한췌담도학회지 Vol.20 No.1
Xanthogranulomatous cholecystitis is an uncommon destructive inflammatory disease with accumulation of lipid-laden macrophages, fibrous tissue, and inflammatory cells. It is often mistaken for gallbladder cancer due to diffuse wall thickening of gallbladder and infiltration into neighboring organs. And it is usually difficult to distinguish xanthogranulomatous cholecystitis from gallbladder cancer based on clinical, radiographic, or laboratory testing. Patients with xanthogranulomatous cholecystitis often undergo cholecystectomy to confirm the diagnosis, and to exclude gallbladder cancers. We report a case of 69-year-old woman with xanthogranulomatous cholecystitis who had been treated with steroid and avoided extended resection.
조소영 ( So Young Jo ),김나영 ( Nayoung Kim ),이정원 ( Jung Won Lee ),임지환 ( Ji Hwan Lim ),최치언 ( Chiun Choi ),전일영 ( Il Young Chon ),길호 ( Ho Kil ),민보영 ( Bo Young Min ),변영상 ( Young Sang Byoun ),이반석 ( Ban Seok Lee 대한소화기학회 2012 대한소화기학회지 Vol.59 No.6
Background/Aims: The aim of this study was to compare polyethylene glycol (PEG) 4 L, split method of PEG 4 L and PEG 2 L plus sodium phosphate (NaP) in the aspect of bowel preparation quality, safety, patients` compliance and preference. Methods: Total 249 subjects were prospectively enrolled and received bowel preparation for colonoscopy from August to October in 2010; PEG 4 L (93 subjects), split method of 4 L PEG (74 subjects) and PEG 2 L plus NaP 90 mL group (82 subjects). To investigate the completion, preference for bowel preparation and safety, a questionnaire survey was conducted before colonoscopy. Results: There were no significant intergroup differences in the aspect of completion of preparation, cecal intubation time and success rate. Satisfaction and preference were higher in PEG 2 L plus NaP 90 mL and split method of 4 L PEG compared with PEG 4 L. In the aspect of the bowel preparation quality PEG 4 L showed significantly higher quality in the morning colonoscopy (p<0.001). However, in the afternoon colonoscopy PEG 2 L plus NaP 90 mL showed better result than PEG 4 L (p=0.009). Hyperphosphatemia was most frequently observed in PEG 2 L plus NaP 90 mL, but no severe adverse events occurred (p<0.001). Conclusions: PEG 4 L showed better result than split method of 4 L PEG or PEG 2 L plus NaP 90 mL in the aspect of bowel preparation quality and safety. (Korean J Gastroenterol 2012;59:414-422)
수술 고위험 중증 환자에게서 발생한 급성 담낭염의 경피적 담낭배액술 단독 치료와 담낭절제술 비교; 단일 기관, 단면 연구
차병효 ( Byung Hyo Cha ),송하헌 ( Ha Hun Song ),김영남 ( Young Nam Kim ),전원중 ( Won Jung Jeon ),이상진 ( Sang Jin Lee ),김진동 ( Jin Dong Kim ),이학현 ( Hak Hyun Lee ),이반석 ( Ban Seok Lee ),이상협 ( Sang Hyub Lee ) 대한소화기학회 2014 대한소화기학회지 Vol.63 No.1
Background/Aims: Percutaneous cholecystostomy (PC) is an effective treatment for cholecystitis in high-risk surgical patients. However, there is no definitive agreement on the need for additional cholecystectomy in these patients. Methods: All patients who were admitted to Cheju Halla General Hospital (Jeju, Korea) for acute cholecystitis and who underwent ultrasonography-guided PC between 2007 and 2012 were consecutively enrolled in this study. Among 82 total patients enrolled, 35 underwent laparoscopic cholecystectomy after recovery and 47 received the best supportive care (BSC) without additional surgery. Results: The technical and clinical success rates for PC were 100% and 97.5%, respectively. The overall mean survival was 12.8 months. In the BSC group, mean survival was 5.4 months, and in the cholecystectomy group, mean survival was 22.4 months (p<0.01). However, there was no significant difference between these groups in multivariate analysis (relative risk [RR]=1.92; 95% CI, 0.77-4.77; p=0.16). However, advanced age (RR=1.05; 95% CI, 1.02-1.08; p=0.001) and higher class in the American Society of Anesthesiologists` physical status (RR=3.06; 95% CI, 1.37-6.83, p=0.006) were significantly associated with survival in the multivariate analysis. Among the 47 patients in the BSC group, the cholecystostomy tube was removed in 31 patients per protocol. Recurrent cholecystitis was not observed in either group of patients during the follow-up period. Conclusions: In high-risk surgical patients, PC without additional cholecystectomy might be the best definitive management. Furthermore, the cholecystostomy drainage catheter can be safely removed in certain patients. (Korean J Gastroenterol 2014;63:32-38)